(NASDAQ: LNSR) Lensar's forecast annual revenue growth rate of 18.74% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.77%, and it is also forecast to beat the US market's average forecast revenue growth rate of 16.3%.
Lensar's revenue in 2026 is $57,704,000.On average, 4 Wall Street analysts forecast LNSR's revenue for 2026 to be $748,810,043, with the lowest LNSR revenue forecast at $708,175,814, and the highest LNSR revenue forecast at $782,907,935. On average, 4 Wall Street analysts forecast LNSR's revenue for 2027 to be $906,226,829, with the lowest LNSR revenue forecast at $757,997,228, and the highest LNSR revenue forecast at $1,053,621,231.
In 2028, LNSR is forecast to generate $1,312,472,285 in revenue, with the lowest revenue forecast at $1,260,907,848 and the highest revenue forecast at $1,351,085,091.